Diabetes Remission Increased With Dapagliflozin Plus Calorie Restriction
Dapagliflozin plus calorie restriction beneficial for patients with overweight or obesity and type 2 diabetes
Considerable Uncertainty Exists Regarding Effects of Puberty Blockers
Two systematic reviews revealed very low-certainty evidence on outcomes for people with gender dysphoria
Calorie Labeling of Foods Leads to Small Reduction in Energy Selected
Larger reduction seen in consumption; evidence insufficient to assess potential modifiers for food consumption
Continuous Glucose Monitoring Can Predict Microvascular Complications in Type 1 Diabetes
Time-in-range computed from virtual CGM data predicts retinopathy, neuropathy similarly to glycated hemoglobin data
Intermittent Fasting Safe, Effective for Reducing Visceral Adipose Tissue
However, it offers no additional benefit than the Mediterranean diet alone for abdominal fat
No Link Seen Between GLP-1 Receptor Agonist Use and Thyroid Cancer
Authors say large, multisite study should provide reassurance for short-term risk
Certain Drug Types Associated With Risk for Dementia
Antimicrobials, vaccines, anti-inflammatories linked to reduced risk for Alzheimer disease and dementia; antipsychotics and diabetes drugs tied to higher risk
GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss
Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders
Websites Selling Compounded GLP-1 RAs Often Misinform Consumers
Only 34 of 79 websites stated that compounded drugs were not FDA approved; 39 websites did not report adverse effects, warnings
Smoking Tied to Lower Earnings, Labor Market Participation
Associations even stronger among those with lower educational attainment
